Observed arrival · 2026-10-18
SupplierVigil maps pharma suppliers to FDA risk records
SupplierVigil says it matches pharmaceutical suppliers to FDA facilities and monitors Warning Letters and OAI/VAI inspection results.
- For
- Pharmaceutical supply and quality teams
- Worth noticing
- Its stated FEI-to-commercial-name mapping is meant to connect buyer-known supplier names with FDA facility records.
Field notes
The page describes a workflow that starts with a buyer-entered supplier name, resolves aliases against FDA establishment identifiers, and presents matched regulatory records for review. It says the matching layer uses FEI-to-commercial-name mapping, and its public alert panel shows counts dated Oct. 18, 2026: 10 Warning Letters, 144 OAI inspections, 822 VAI inspections, and 501 suppliers mapped. The site says clean NAI inspections are excluded from its risk totals; these figures and matching performance are not independently verified here.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
One card from the complete issue